18
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
April 30, 2016
Vitamin E δ-Tocotrienol
Vitamin E δ-Tocotrienol will be administered orally as a single agent twice daily for 14 consecutive days. Vitamin E δ-Tocotrienol is supplied as 100-mg, 200-mg, and 400-mg capsules. The first cohort will be dosed with δ-tocotrienol at 100 mg twice daily for 14 consecutive days. A minimum of 3 subjects is planned for each dosing cohort with Vitamin E δ-Tocotrienol dose escalation dependent on safety and available PK data from prior cohorts. At the MTD or MAD, 18 subjects will be enrolled.
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Collaborators (1)
National Cancer Institute (NCI)
NIH
BioGene Life Science
INDUSTRY
H. Lee Moffitt Cancer Center and Research Institute
OTHER